Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (rel)-Eglumegad ((rel)-LY354740) | 176027-90-0 | 97.0% | 185.18 | 1 ML
SDP

Catalog No. 5000385276
Encompass_Preferred

(rel)-Eglumegad ((rel)-LY354740) is a relative configuration of Eglumegad and functions as a highly potent and selective group II (mGlu2/3) receptor agonist. This product is formulated as a 10 mM * 1 mL solution in water, ready for reconstitution, making it suitable for various research applications requiring precise control over mGlu2/3 receptor activity.

  • Potent and selective group II (mGlu2/3) receptor agonist
  • EC50s of 5 nM for mGlu2 and 24 nM for mGlu3 receptors
  • Formulated as a 10 mM * 1 mL solution in water
  • Ready for reconstitution
  • Storage in solvent at -80°C for 6 months or -20°C for 1 month

Catalog No. 50-003-85276 Supplier Medchemexpress LLC Supplier No. HY18941B10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(rel)-Eglumegad ((rel)-LY354740) is a relative configuration of Eglumegad and functions as a highly potent and selective group II (mGlu2/3) receptor agonist. This product is formulated as a 10 mM * 1 mL solution in water, ready for reconstitution, making it suitable for various research applications requiring precise control over mGlu2/3 receptor activity.

  • Potent and selective group II (mGlu2/3) receptor agonist
  • EC50s of 5 nM for mGlu2 and 24 nM for mGlu3 receptors
  • Formulated as a 10 mM * 1 mL solution in water
  • Ready for reconstitution
  • Storage in solvent at -80°C for 6 months or -20°C for 1 month

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.